My love affair with research started as early as 2008, where we were initially intrigued at how antibodies can impact outcome of dengue virus infection. I became very interested in data science. By integrating various omics platforms, we were able to understand how human variations and host responses affect immunogenicity and adverse events to the Yellow Fever vaccine.